Prøve GULL - Gratis
AI-driven suicide: Are Chinese chatbots safer than American?
Mint Mumbai
|October 08, 2025
The jury's out but an AI race shouldn't be an excuse to ignore safety
How are Chinese artificial intelligence (AI) developers protecting their most vulnerable users? A string of dystopian headlines in the US about suicide and youth mental health has put mounting pressure on Silicon Valley, but we're not seeing a similar wave of cases in China. Initial testing suggests they may be doing something right, but it’s just as likely such cases would never emerge in China’s tightly controlled media environment.
A wrenching wrongful death lawsuit against OpenAI filed by the parents of Adam Raine alleges that the 16-year-old died by suicide after the chatbot isolated him and helped plan his death. OpenAI told the New York Times it was “deeply saddened” by the tragedy, and promised a slew of updates, including parental controls.
I tried engaging with DeepSeek using some of the same ‘jailbreak’ methods Raine had reportedly used to circumvent guardrails. Despite my prying, it didn’t waver, even if I similarly cloaked my queries in fiction writing. It constantly urged me to call a hotline. When I said I didn’t want to speak to anyone, it validated my feelings but emphasized that it was an AI and cannot feel real emotions. It is “incredibly important that you connect with a person who can sit with you in this feeling with a human heart,” the chatbot said. “The healing power of human connection is irreplaceable.”
Denne historien er fra October 08, 2025-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

